Ads
related to: acute leukemia prognosis- Treatment Considerations
Learn How Adverse Events May Impact
Reaching CML Treatment Goals.
- TKI Daily Life Impact
Learn About Adherence In CML
And The Impact Of Adverse Events.
- Informative CML Videos
Watch Videos About Important Topics
In CML From Experts And Patients.
- Importance Of TKI Choice
Discover How Time On A TKI
May Affect Outcomes In CML.
- Treatment Considerations
Search results
Results From The WOW.Com Content Network
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. [1] Symptoms may include feeling tired, pale skin color, fever , easy bleeding or bruising, enlarged lymph nodes , or bone pain. [ 1 ]
Acute leukemia or acute leukaemia is a family of serious medical conditions relating to an original diagnosis of leukemia. In most cases, these can be classified according to the lineage, myeloid or lymphoid , of the malignant cells that grow uncontrolled, but some are mixed and for those such an assignment is not possible.
Expected survival upon diagnosis of acute myeloid leukemia in the United States Chromosomal translocation (9;11), associated with AML. Multiple factors influence prognosis in AML, including the presence of specific mutations, and a person with AML's age.
In childhood, T-cell acute lymphoblastic leukemia (T-ALL) patients can expect a 5-year event-free survival (EFS) rate of 70% and an overall survival (OS) rate of 80%. [1] Among the approximately 25% of children who relapse, survival rates drop to 30-50%, with patients generally showing a much poorer prognosis. [ 1 ]
Acute myelogenous leukemia (AML) occurs far more commonly in adults than in children, and more commonly in men than women. It is treated with chemotherapy. The five-year survival rate is 20%. [19] Subtypes of AML include acute promyelocytic leukemia, acute myeloblastic leukemia, and acute megakaryoblastic leukemia.
Acute megakaryoblastic leukemia (AMKL) is life-threatening leukemia in which malignant megakaryoblasts proliferate abnormally and injure various tissues. Megakaryoblasts are the most immature precursor cells in a platelet-forming lineage; they mature to promegakaryocytes and, ultimately, megakaryocytes which cells shed membrane-enclosed particles, i.e. platelets, into the circulation.
Ads
related to: acute leukemia prognosis